McCandless Shawn E, Wright Erica J
Department of Pediatrics, Section of Genetics and Metabolism, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Birth Defects Res. 2020 Mar 1;112(4):350-366. doi: 10.1002/bdr2.1653.
Beginning in the 1960s, mandatory newborn screening (NBS) of essentially all infants has been a major public health success story. NBS is not just a blood test, rather, it is a complex, integrated system that begins with timely testing, scrupulous follow up of patients, tracking of outcomes, quality improvement of all aspects of the process, and education of providers, staff, and parents. In the past, expansion of NBS programs has been driven by new testing technology, but now is increasingly driven by the development of novel therapeutics and political advocacy. Each state determines how the NBS system will be structured in that state, but there is increasing oversight and support for harmonization at a federal level. Several recent initiatives, together with the increased number of conditions screened and the concomitant increase in burdensome false-positive tests, are creating new scrutiny of NBS systems, and potentially pose an existential risk to the public acceptance of mandatory NBS. The history, current state and challenges for NBS are explored in this issue, with some suggestions as to how to address them.
从20世纪60年代开始,对基本上所有婴儿进行强制性新生儿筛查(NBS)一直是公共卫生领域的一个重大成功案例。NBS不仅仅是一项血液检测,相反,它是一个复杂的综合系统,始于及时检测、对患者的严格随访、结果追踪、流程各方面的质量改进以及对医疗服务提供者、工作人员和家长的教育。过去,NBS项目的扩展由新的检测技术推动,但现在越来越多地由新型疗法的发展和政治倡导推动。每个州决定该州的NBS系统将如何构建,但联邦层面的监督和协调支持在不断增加。最近的几项举措,加上筛查疾病数量的增加以及随之而来的繁琐假阳性检测的增多,正在引发对NBS系统的新审视,并可能对强制性NBS的公众接受度构成生存风险。本期探讨了NBS的历史、现状和挑战,并就如何应对这些问题提出了一些建议。